Join the Coumadin group to help and get support from people like you.
Coumadin News
Warfarin Cuts Mortality, Thromboembolism After Valve Replacement
THURSDAY, Jan. 4, 2024 – Warfarin use after bioprosthetic surgical aortic valve replacement (sAVR) is associated with lower all-cause mortality and a decreased risk for thromboembolism compared with...
Bleeding Higher With Standard-Dose DOACs in Nonvalvular A-Fib
THURSDAY, Nov. 16, 2023 – For nursing home residents with nonvalvular atrial fibrillation, the rate of bleeding is higher with standard- versus reduced-dose direct acting oral anticoagulants...
DOACs Reduce Dementia Risk Versus Warfarin in A-Fib
THURSDAY, Sept. 7, 2023 – For patients with atrial fibrillation (AF), the use of direct-acting oral anticoagulants (DOACs) significantly reduces dementia risk compared with warfarin, according to a...
Prolonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE
MONDAY, Aug. 21, 2023 – For patients with venous thromboembolism (VTE) continuing warfarin or direct oral anticoagulants (DOACs) beyond six months, the risk for recurrent VTE is lower with DOACs,...
FDA Medwatch Alert: Coumadin (warfarin sodium) for Injection by Bristol-Myers Squibb: Recall - Particulate Matter
ISSUE: Bristol-Myers Squibb Company issued a voluntary recall of six lots of Coumadin for Injection, 5 mg single-use vials in the U.S. Visible particulate matter was found in a small number of ...
FDA Medwatch Alert: Warfarin 2 mg Tablets by Zydus Pharmaceuticals USA Inc.: Recall - Due to Oversized Tablets
ISSUE: Zydus Pharmaceuticals USA Inc. is voluntarily recalling one lot of Warfarin 2 mg Tablets, Lot #MM5767, expiration date June 2014 to the retail level. Four tablets of Warfarin 2 mg Tablets, Lot...
FDA Medwatch Alert: Coumadin (warfarin sodium) Crystalline 5 mg Tablets: Recall - Tablets May Have Higher than Expected Potency
ISSUE: Bristol-Myers Squibb initiated a voluntary recall of one lot of 1,000-count bottles of Coumadin (warfarin sodium) Crystalline 5 mg tablets. Company testing of tablets from a returned bottle...
FDA Medwatch Alert: Warfarin (marketed as Coumadin)
[Posted 08/16/2007] FDA approved updated labeling to include pharmacogenomics information to the CLINICAL PHARMACOLOGY, PRECAUTIONS, and DOSAGE AND ADMINISTRATION sections of the prescribing...
FDA Medwatch Alert: Coumadin (warfarin sodium)
[Posted 10/06/2006] FDA and Bristol-Myers Squibb notified pharmacists and physicians of revisions to the labeling for Coumadin, to include a new patient Medication Guide as well as a reorganization...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Thromboembolic Stroke Prophylaxis, Pulmonary Embolism - Recurrent Event, Pulmonary Embolism - First Event, Prevention of Thromboembolism in Atrial Fibrillation, Heart Failure, Congestive Heart Failure, Myocardial Infarction, Heart Attack, Deep Vein Thrombosis - Recurrent Event, Deep Vein Thrombosis - First Event